Latest Rheumatology Stories
The research team at Avail Clinical is conducting new clinical studies in DeLand, FL.
The research team at Achieve Clinical is conducting a new clinical study in Birmingham, AL.
Testing for the protein 14-3-3eta may improve the diagnosis of RA, including in early stages when treatment is most likely to improve outcomes MADISON, N.J., Aug.
On September 17, $10 from Every Massage or Facial Will Benefit the Arthritis Foundation LOS ANGELES, Aug.
On September 17, $10 from every massage or facial benefits the Arthritis Foundation SAN FRANCISCO, Aug.
Be Joint Smart to educate roughly 43,500 local residents with PsA about their disease PORTLAND, Ore., Aug. 20, 2014 /PRNewswire-USNewswire/ -- If you're one of the roughly 43,500 D.C.
DANVERS, Mass., Aug. 19, 2014 /PRNewswire-USNewswire/ -- The Scleroderma Foundation presented a Lifetime Achievement Award to Virginia D.
Nearly 80 Percent of Surveyed Physicians Believe Xeljanz is Superior to Methotrexate in Inhibiting Structural Progression in RA, According to Findings from Decision Resources Group BURLINGTON,
Expert from the Largest Scleroderma Specialty Center in the U.S. at Johns Hopkins will Provide Insight to Help Patients, Physicians and Caregivers. SAN FRANCISCO, Aug.
A new mechanism of joint destruction caused by a natural material that grinds away healthy cartilage and worsens osteoarthritis has been identified in human hip joints for the first time by University of Liverpool scientists.